{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:25:07Z","timestamp":1785536707472,"version":"3.56.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Hanns-Seidel-Stiftung e.V"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.09.087","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T17:57:58Z","timestamp":1571421478000},"page":"7207-7212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A study with a commercial vaccine against Lyme borreliosis in horses using two different vaccination schedules: Characterization of the humoral immune response"],"prefix":"10.1016","volume":"37","author":[{"given":"Jasmin M.","family":"Kn\u00f6dlseder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari F.","family":"Fell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard K.","family":"Straubinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.087_b0005","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease - a tick borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.09.087_b0010","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1128\/AEM.00116-09","article-title":"A new Borrelia species defined by multilocus sequence analysis of housekeeping genes","volume":"75","author":"Margos","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.087_b0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5604\/12321966.1152074","article-title":"Polysynovitis in a horse due to Borrelia burgdorferi sensu lato infection\u2013Case study","volume":"22","author":"Passamonti","year":"2015","journal-title":"Ann Agric Environ Med."},{"key":"10.1016\/j.vaccine.2019.09.087_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.2042-3306.1996.tb01595.x","article-title":"A possible case of Lyme borreliosis in a horse in the UK","volume":"28","author":"Hahn","year":"1996","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2019.09.087_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-3164.2011.01013.x","article-title":"A case of Borrelia-associated cutaneous pseudolymphoma in a horse","volume":"23","author":"Sears","year":"2011","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.vaccine.2019.09.087_b0030","series-title":"Qualit\u00e4tsstandards in der mikrobiologisch-infektiologischen Diagnostik","first-page":"23","article-title":"MiQ 12,20 Lyme Borreliose","author":"Wilske","year":"2001"},{"key":"10.1016\/j.vaccine.2019.09.087_b0035","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.vaccine.2015.07.095","article-title":"Characterization and optimization of a novel vaccine for protection against Lyme borreliosis","volume":"33","author":"Comstedt","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.087_b0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/iai.63.9.3543-3549.1995","article-title":"Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi","volume":"63","author":"Chang","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.09.087_b0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0264-410X(99)00187-5","article-title":"Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses","volume":"18","author":"Chang","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.087_b0050","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/iai.65.3.882-889.1997","article-title":"Reactivity with a specific epitope of outer surface protein a predicts protection from infection with the lyme diesease spirochete, borrelia burgdorferi","author":"Golde","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.09.087_b0055","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0264-410X(97)00066-2","article-title":"Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss Borrelia garinii and Borrelia afzelii","volume":"15","author":"Gern","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.087_b0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/infdis\/167.3.651","article-title":"Experimental Lyme disease in dogs produces arthritis and persistent infection","volume":"167","author":"Appel","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.087_b0065","first-page":"172","article-title":"Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs","volume":"11","author":"Jacobson","year":"1996","journal-title":"Semin Vet Med Surg."},{"key":"10.1016\/j.vaccine.2019.09.087_b0070","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/514779","article-title":"Alternative vaccination schedules (0, 1, and 6 months versus 0,1, and 12 months) for a recombinant OspA Lyme disease vaccine","volume":"28","author":"Van Hoecke","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.087_b0075","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2017.06.052","article-title":"Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses","volume":"35","author":"Guarino","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.087_b0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vaccine.2006.07.031","article-title":"Characterization of the humoral immune response in dogs after vaccination against the Lyme borreliosis agent A study with five commercial vaccines using two different vaccination schedules","volume":"25","author":"T\u00f6pfer","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.087_b0085","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/IAI.73.3.1644-1647.2005","article-title":"Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within Ticks","author":"Gipson","year":"2005","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:08Z","timestamp":1759401368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":17,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19313295"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study with a commercial vaccine against Lyme borreliosis in horses using two different vaccination schedules: Characterization of the humoral immune response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}